Physician profile
George Palmer
NPI 1194718080
$1,594.78
in general payments reported to CMS, 2019-2025
24 companies · $210 in 2025
The $210 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $154 · 2021: $365 · 2022: $346 · 2023: $178 · 2024: $169 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.80 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $406.58 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $147.99 | 2019-2024 | |
| Novo Nordisk INC | $141.85 | 2021-2025 | Wegovy |
| Hologic Sales and Service, LLC | $134.86 | 2021-2024 | Aptima |
| Abbvie INC. | $117.60 | 2019-2021 | |
| Myovant Sciences INC. | $85.67 | 2021-2022 | |
| Caldera Medical, INC | $81.63 | 2022 | |
| Evofem Biosciences, INC. | $72.97 | 2021 | |
| Sumitomo Pharma America, INC. | $55.90 | 2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $42.29 | 2019-2025 | |
| Biogen, INC. | $39.76 | 2025 | Zurzuvae |
| Medtronic Vascular, INC. | $33.08 | 2020 | |
| Organon LLC | $32.87 | 2022 | |
| Exeltis, USA INC. | $30.79 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $26.18 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.41 | 2025 | Zepbound |
| Therapeuticsmd, INC. | $20.58 | 2020 | |
| Medtronic, INC. | $20.05 | 2021 | |
| Scynexis, INC. | $15.75 | 2022 | |
| Aspira Women'S Health INC | $14.91 | 2024 | Ova1 |
| Amgen INC. | $14.57 | 2021 | |
| Currax Pharmaceuticals LLC | $13.66 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $12.39 | 2019 | |
| Eisai INC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.